Novel anti-cancer drug Tigilanol Tiglate efficacy study finds 90% complete response observed at the highest drug concentration (1.0 mg/mL) and adverse events were generally low grade, mild and transient, and directly associated with the mode of action of the drug. User Schematic98, in the Future(s) Studies subreddit, 09 Apr 2019
Novel anti-cancer drug Tigilanol Tiglate efficacy study finds 90% complete response observed at the highest drug concentration (1.0 mg/mL) and adverse events were generally low grade, mild and transient, and directly associated with the mode of action of the drug. User Schematic98, in the Reddit Science subreddit, 09 Apr 2019